Manufacturing & Analytical Characterization
Andrew Argo, MSc (he/him/his)
Sr. Global Marketing Manager
Waters Corp.
Description: The development pipeline for oligonucleotide-based therapeutics continues to expand, as does demand for GMP oligos for clinical diagnostics. The modifications to these nucleic acids that make them stable, selective, and effective drugs have created the need for easy-to-use analytical tools and workflow solutions that deliver high quality results, improve efficiency, and enable regulatory compliance. From characterization to impurity monitoring, DMPK studies, formulation, QC release, and more, this presentation will discuss a range of LC-MS workflows that deliver maximum sensitivity, high selectivity, and repeatability. We will highlight automated compliance-ready data acquisition and processing tools that streamline data analysis, reporting, and facilitate the sharing of data/information across systems, labs, and geographies for enhanced productivity and reduced risk.